Home / PDA Letters (Cards)

PDA Letters (Cards)

What Annex 1 Means for Sterilization and Moist Steam

Walid El Azab, STERIS Life Science

Data Integrity in the Age of Metadata and Big Data

Toni Manzano, bigfinite

Biologics Packaging Presents Risks

Alessandro Morandotti, Ompi

Draft Annex 1 Separates Cleaning and Disinfection

James Tucker, Ecolab Life Sciences

A Wealth of New Micro Regulations

Michael Miller, PhD, Microbiology Consultants

Revised USP Micro Chapters Address Changing Technologies

David Hussong, PhD, Eagle Analytical Services, Radhakrishna Tirumalai, PhD, USP, Edward Tidswell, PhD, Merck, and Donald Singer, GSK

Strategies to Address E/L Container Closure Challenges

Rebecca Stauffer, PDA

Industry Converges on Pharmacopeial Convergence

Rebecca Stauffer, PDA

India Chapter Goes into the Cold

Biny Joseph, PDA India Chapter Coordinator

Visual Inspection Workshop Addresses Annex 1, New Tech

John Shabushnig, PhD, Insight Pharma Consulting; Rick Watson, Merck and Rob Miller, Pfizer

Russian GMP Inspections Present Challenges, Opportunities: Part II

Vladislav Shestakov, Russian State Institute of Drugs and Good Practices, and Elizabeth Meyers, Amgen

Russian GMP Inspections Present Challenges, Opportunities: Part I

Vladislav Shestakov, Russian State Institute of Drugs and Good Practices, and Elizabeth Meyers, Amgen

Not So Different After All

Rebecca Stauffer, PDA

Reclaiming Efficiency Amid Serialization Nightmares

Vito Pirrera and John Jordon, Vantage Solutions

Evaluating Cell Viability After Cryopreservation

Brian J. Hawkins, Alireza Abazari, Aby J. Mathew, BioLife Solutions

PDA Participates in Nipro Experience Days

Janie (Jahanvi) Miller, PDA

New Serialization Regs Impact Global Pharma

Darryl Peterson, Antares Vision

2018 PDA Summer Reading

Rebecca Stauffer, PDA

A Risk-Based Approach to Supplier Management

Rebecca Stauffer and Aneeta Mathur-Ashton, PDA

Viscous Product No Match for New CCI Tech

Oliver Stauffer, PTI